Cocrystal Pharma Inc (COCP)

[thomasg]

Posted by Ethan Ryder on Aug 14th, 2014 // No Comments
Share on StockTwits This looks good to me.
Cocrystal Pharma Inc logoCocrystal Pharma (NASDAQ:COCP) Director Phillip Md Et Al Frost purchased 111,200 shares of Cocrystal Pharma stock in a transaction dated Tuesday, August 12th. The stock was purchased at an average cost of $0.29 per share, with a total value of $32,248.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Shares of Cocrystal Pharma (NASDAQ:COCP) traded up 4.55% during mid-day trading on Thursday, hitting $0.345. 90,018 shares of the company’s stock traded hands. Cocrystal Pharma has a 1-year low of $0.23 and a 1-year high of $0.97. The stock has a 50-day moving average of $0.29 and a 200-day moving average of $0.42. The company’s market cap is $42.0 million.
Cocrystal Pharma Inc, formerly Biozone Pharmaceuticals, Inc, through its wholly owned subsidiary, BioZone Laboratories, Inc (NASDAQ:COCP), primarily is engaged in the business of developing and manufacturing over the counter (OTC) drug products and cosmetic and beauty products on behalf of third parties.